NormanL.SussmanMD
Gastroenterology • Houston, TXHepatology & Liver Transplantation
Associate Professor
Dr. Sussman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6620 Main St
Ste 1475
Houston, TX 77030Phone+1 713-798-8100Fax+1 713-798-4530
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 1981 - 1985
University of the WitwatersrandClass of 1976
Certifications & Licensure
TX State Medical License 1985 - 2026
UT State Medical License 2008 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 75 citationsNo Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades.Abbas Rana, Ruth L. Ackah, Gwilym J. Webb, Karim J. Halazun, John M. Vierling
Annals of Surgery. 2018-01-01 - 351 citationsPilot‐controlled trial of the extracorporeal liver assist device in acute liver failureA J Ellis, Robin D. Hughes, Julia Wendon, Dunne Jb, Peter G. Langley
Hepatology. 1996-12-01 - 4 citationsAutoimmune Hepatitis in a Patient With Common Variable Immunodeficiency.Kanchana Myneedu, Luis O Chavez, Norman Sussman, Majd Michael, Angelica Padilla
ACG Case Reports Journal. 2021-03-17
Journal Articles
- Project ECHO: The Specialist Will See You NowNorman Sussman, Saira Khaderi, Fasiha Kanwal, Hepatology
- Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by an Expert Committee to Establish CausalityDaniel R Ganger, Norman Sussman, Charles Chiu, R T Stravitz, Laura James, Nathan Bass, Anne M Larson, Jorge Rakela, William M Lee, Nature
Lectures
- 2013 National End Stage Liver Disease Training Program and Treatment Update - HoustonScripps Conference Services & CME /Scripps Translational Science Institute (STSI), Houston, Texas - 8/10/2013
Other
- Overview of immunosuppression in adult liver transplantationSussman NL, Vierling JM
http://www.uptodate.com/contents/overview-of-immunosuppression-in-adult-liver-transplantation
UpToDate, Wolters Kluwer Health - 2013-03-12
Press Mentions
DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-Associated HepatitisSeptember 25th, 2024- DURECT Corporation to Host Webinar on the Treatment of Alcoholic Hepatitis Featuring Chief Medical Officer Dr. Norman SussmanNovember 10th, 2020
- DURECT Corporation Appoints Dr. Norman Sussman as Chief Medical OfficerNovember 2nd, 2020
- Join now to see all
Grant Support
- Biosynthesis Of Liver Alkaline PhosphataseNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
